ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 128 filers reported holding ALLAKOS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,023 | -85.8% | 10,583 | -47.3% | 0.00% | -85.0% |
Q4 2022 | $169,040 | -61.2% | 20,076 | -85.6% | 0.02% | -44.4% |
Q2 2022 | $436,000 | -53.7% | 139,210 | -15.6% | 0.04% | -54.4% |
Q1 2022 | $941,000 | -24.3% | 165,032 | +30.0% | 0.08% | -28.2% |
Q4 2021 | $1,243,000 | +362.1% | 126,934 | +4901.3% | 0.11% | +243.8% |
Q3 2021 | $269,000 | +22.3% | 2,538 | -1.4% | 0.03% | -5.9% |
Q2 2021 | $220,000 | – | 2,574 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |